Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Regulatory Status and Current Safety Considerations Retatrutide holds no MHRA or EMA marketing authorisation and is available only within authorised clinical trials
The side effect comparison between the two medications shows some differences worth considering
Stability and bioactivity of Qkine IGF-1 LR3 (Qk041)
Deanfield, J., et al
Structurally it is a pentapeptide with a C-terminal amide and two D-amino acids, both features contributing to protease resistance
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
